These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10415737)

  • 1. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats.
    Golub LM; Ramamurthy NS; Llavaneras A; Ryan ME; Lee HM; Liu Y; Bain S; Sorsa T
    Ann N Y Acad Sci; 1999 Jun; 878():290-310. PubMed ID: 10415737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study.
    Ramamurthy N; Bain S; Liang CT; Barnes J; Llavaneras A; Liu Y; Puerner D; Strachan MJ; Golub LM
    Curr Med Chem; 2001 Feb; 8(3):295-303. PubMed ID: 11172684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats.
    Llavaneras A; Ramamurthy NS; Heikkilä P; Teronen O; Salo T; Rifkin BR; Ryan ME; Golub LM; Sorsa T
    J Periodontol; 2001 Aug; 72(8):1069-77. PubMed ID: 11525440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chemically modified tetracycline, CMT-8, on bone loss and osteoclast structure and function in osteoporotic states.
    Sasaki T; Ohyori N; Debari K; Ramamurthy NS; Golub LM
    Ann N Y Acad Sci; 1999 Jun; 878():347-60. PubMed ID: 10415740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression.
    Pirilä E; Ramamurthy N; Maisi P; McClain S; Kucine A; Wahlgren J; Golub L; Salo T; Sorsa T
    Curr Med Chem; 2001 Feb; 8(3):281-94. PubMed ID: 11172683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease.
    Ramamurthy NS; Xu JW; Bird J; Baxter A; Bhogal R; Wills R; Watson B; Owen D; Wolff M; Greenwald RA
    J Periodontal Res; 2002 Feb; 37(1):1-7. PubMed ID: 11842933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and their inhibition in periodontal treatment.
    Ryan ME; Ramamurthy S; Golub LM
    Curr Opin Periodontol; 1996; 3():85-96. PubMed ID: 8624573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMT-8/clodronate combination therapy synergistically inhibits alveolar bone loss in LPS-induced periodontitis.
    Llavaneras A; Golub LM; Rifkin BR; Heikkilä P; Sorsa T; Teronen O; Salo T; Liu Y; Ryan ME; Ramamurthy NS
    Ann N Y Acad Sci; 1999 Jun; 878():671-4. PubMed ID: 10415804
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term therapy with a new chemically modified tetracycline (CMT-8) inhibits bone loss in femurs of ovariectomized rats.
    Sasaki T; Ramamurthy NS; Golub LM
    Adv Dent Res; 1998 Nov; 12(2):76-81. PubMed ID: 9972126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases.
    Sorsa T; Ding Y; Salo T; Lauhio A; Teronen O; Ingman T; Ohtani H; Andoh N; Takeha S; Konttinen YT
    Ann N Y Acad Sci; 1994 Sep; 732():112-31. PubMed ID: 7978785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Root-surface caries in rats and humans: inhibition by a non-antimicrobial property of tetracyclines.
    Ramamurthy NS; Schroeder KL; McNamara TF; Gwinnett AJ; Evans RT; Bosko C; Golub LM
    Adv Dent Res; 1998 Nov; 12(2):43-50. PubMed ID: 9972121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.
    Vernillo AT; Ramamurthy NS; Golub LM; Rifkin BR
    Curr Opin Periodontol; 1994; ():111-8. PubMed ID: 8032451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases.
    Sorsa T; Ramamurthy NS; Vernillo AT; Zhang X; Konttinen YT; Rifkin BR; Golub LM
    J Rheumatol; 1998 May; 25(5):975-82. PubMed ID: 9598901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats: effects on matrix metalloproteinase-2, membrane type 1 matrix metalloproteinase, and laminin-5 gamma2-chain.
    Pirilä E; Parikka M; Ramamurthy NS; Maisi P; McClain S; Kucine A; Tervahartiala T; Prikk K; Golub LM; Salo T; Sorsa T
    Wound Repair Regen; 2002; 10(1):38-51. PubMed ID: 11983005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats.
    Golub LM; Evans RT; McNamara TF; Lee HM; Ramamurthy NS
    Ann N Y Acad Sci; 1994 Sep; 732():96-111. PubMed ID: 7978855
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in the periodontium after ovariectomy in rats: the effects of a Japanese herbal medicine, Chujo-to.
    Hidaka S; Okamoto Y; Yamada Y; Miyazaki K; Kimura T
    Phytother Res; 2000 Nov; 14(7):527-33. PubMed ID: 11054843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity.
    Ryan ME; Usman A; Ramamurthy NS; Golub LM; Greenwald RA
    Curr Med Chem; 2001 Feb; 8(3):305-16. PubMed ID: 11172685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.